FdaApplication

NDA 211939

Back to search

Identifiers

Properties

PropertyValue
applicant_nameALVOGEN INC
application_typeNDA
approval_date2019-10-04

Products (1)

ProductActive ingredientStrengthDosage form
BONSITYTERIPARATIDE0.56MG/2.24ML (0.25MG/ML)SOLUTION;SUBCUTANEOUS

1 product